AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand
12 nov. 2024 16h03 HE
|
AVITA Medical
AVITA Medical announces exclusive distribution agreement to expand the RECELL product platform to Australia and New Zealand.
AVITA Medical Reports Third Quarter Financial Results
07 nov. 2024 16h03 HE
|
AVITA Medical
AVITA Medical reported third-quarter commercial revenue of $19.5 million, reflecting an approximately 44% increase over the same period last year.
AVITA Medical to Present at 2024 Cantor Global Healthcare Conference
12 sept. 2024 16h05 HE
|
AVITA Medical
AVITA Medical to present at the 2024 Cantor Global Healthcare Conference on September 18, 2024, at 9:10 a.m. Eastern Time.
AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific
10 janv. 2024 16h01 HE
|
AVITA Medical
AVITA Medical announced exclusive multi-year distribution agreement with Stedical Scientific, Inc. to commercialize PermeaDerm in the United States.
AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update
10 janv. 2024 09h01 HE
|
AVITA Medical
AVITA Medical announced preliminary unaudited financial highlights for the fourth quarter 2023, 2024 financial guidance, and full enrollment of TONE.
AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04 janv. 2024 09h00 HE
|
AVITA Medical
AVITA Medical to present at JP Morgan's Annual Healthcare Conference in San Francisco on Thursday, January 11, 2024.
AVITA Medical to Host Investor Webinar Briefing
04 déc. 2023 09h00 HE
|
AVITA Medical
AVITA Medical to host investor webinar briefing on December 5, 2023, at 2:00 p.m. PST. Register at https://rebrand.ly/Dec2023webinar
AVITA Medical Announces Distribution Partnership with PolyMedics Innovations to Expand to Europe
09 nov. 2023 09h00 HE
|
AVITA Medical
AVITA Medical announced it has entered into a distribution agreement with PolyMedics Innovations, to strategically expand its global presence to Europe.